Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-04-12

Clinical Trial Update: Does Gabapentin Reduce Quadriceps Muscle Weakness After Anterior Cruciate Ligament Reconstruction? [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update evaluating whether gabapentin reduces quadriceps muscle weakness after anterior cruciate ligament reconstruction, spanning Phase 2 and P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gabapentin (Gabapentin)

Snippet

Sponsor: Hospital Authority, Hong Kong | Conditions: Muscle Weakness, Anterior Cruciate Ligament Rupture | Phase 2, Phase 3 | Status: UNKNOWN